EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.
FOR RESEARCH ANDCOMERCIAL USE IVD ONLY (*)
(*) Our biomarkers are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our biomarkers, you can visit here.